BillionToOne, Inc. BillionToOne, Inc.

BillionToOne, Inc.

BLLN

Ранг среди акций #3474
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Цена акции
$105.11
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$4.96B
Изменение (1 день)
1.56%
Изменение (1 год)
-
Страна
US
Торговля BillionToOne, Inc. (BLLN)

Категория

Healthcare
История дроблений акций BillionToOne, Inc. (BLLN)
Акции BillionToOne, Inc. (символ: BLLN) прошли через 0 дроблений.
Последнее дробление произошло Oct 22, 2026.
Одна акция BLLN, купленная до Oct 22, 2026, сейчас соответствует 0 акциям BLLN.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
8 x34
US
7 x47
US
0 -
US
0 -
CN
1 x1
US